Introduction
respiratory infections, thrombotic
RESPIRATORY INFECTIONS, EVENTS, DISEASE
Patients with COVID-19 exhibit a higher risk of thrombotic events and a greater magnitude of disease severity than those with respiratory infections of other causes [Non-vitamin K dependent oral inhibitors of factor Xa (NOAC) such as rivaroxaban are widely administered for thromboprophylaxis due to their effectivity to prevent thrombotic events and safety profile [